FDA
approval
· 2020-09-24
FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
Summary
FDA approved a supplemental application for REYATAZ (atazanavir), indicating a modification to the approved labeling. The submission was filed by E.R. Squibb & …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for REYATAZ (ATAZANAVIR)